Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SAGENT PHARMS INC

  • FDA Approval
  • Sept. 21, 2023, 11:47 UTC
  • 45
  • 0 comments

FDA approve DAPTOMYCIN

Comment Full text

INFORLIFE

  • FDA Approval
  • Sept. 21, 2023, 11:47 UTC
  • 29
  • 0 comments

FDA approve METRONIDAZOLE

Comment Full text

CATALENT

  • FDA Approval
  • Sept. 21, 2023, 11:47 UTC
  • 28
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text

TARO

  • FDA Approval
  • Sept. 21, 2023, 11:47 UTC
  • 31
  • 0 comments

FDA approve PHENYTOIN

Comment Full text

DR REDDYS

  • FDA Approval
  • Sept. 20, 2023, 11:45 UTC
  • 34
  • 0 comments

FDA approve TREPROSTINIL

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 20, 2023, 11:45 UTC
  • 30
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Sept. 20, 2023, 11:45 UTC
  • 31
  • 0 comments

FDA approve AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Sept. 20, 2023, 11:45 UTC
  • 29
  • 0 comments

FDA approve CLINDAMYCIN PHOSPHATE

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 20, 2023, 11:45 UTC
  • 31
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

PRINSTON INC

  • FDA Approval
  • Sept. 20, 2023, 11:45 UTC
  • 30
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text
  • Previous
  • 673
  • 674
  • 675
  • 676
  • 677
  • Next

Search

News categories

  • Technical Exchange News(11991)
  • Event(5163)
  • SEC News(248756)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149651)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin